Family · Pharmaceutical analytical standards
Calcipotriol
A synthetic vitamin D analogue patented in 1985 and in use since 1991: applied to the skin as a cream or ointment, it slows the proliferation of keratinocytes in plaque psoriasis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It binds the vitamin D receptor almost as well as calcitriol, the natural hormone, but it is over a hundred times less active on calcium metabolism: this is why it can be used on the skin with less risk of upsetting it.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
